Neuroderm Revenue, Profits - NDRM Quarterly Income Statement

Add to My Stocks
$38.85 $0 (0%) NDRM stock closing price Oct 18, 2017 (Closing)

Financial analysis of Neuroderm involves more than just checking the Neuroderm stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. Like any other income statement, the NDRM income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of 0 when compared to the same period in the past. One also needs to look at Neuroderm assets, operating expenses and Neuroderm free cash flow. The Neuroderm profit and loss statement shows revenue of $- for 2017 Q2. Revenue has decreased by 0 QoQ for NDRM stock.

View and download details of revenue and profits for Neuroderm for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Neuroderm Revenues or Net Sales
------
Cost Of Goods Sold (COGS)------
Neuroderm Gross Profit
------
Research & Development Expense11.14M10.14M9.52M7.8M5.55M4.13M
Selling General & Admin Expense4.21M3.27M1.66M1.43M1.44M1.55M
Income Before Depreciation Depletion Amortization-15.36M-13.41M-11.18M-9.23M-7M-5.68M
Depreciation Depletion Amortization------
Non Operating Income------
Interest Expense------
Neuroderm Pretax Income
-14.93M-13.05M-11.09M-9.1M-6.95M-5.35M
Provision for Income Taxes------
MinorityInterest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-14.94M-13.05M-11.1M-9.1M-6.95M-5.35M
Extraordinary Items & Discontinued Operations------
Neuroderm Profit/ Loss (Net Income)
-14.94M-13.05M-11.1M-9.1M-6.95M-5.35M
Average Shares used to compute Diluted EPS26.21M26.1M22.65M21.67M21.72M21.4M
Average Shares used to compute Basic EPS26.21M26.1M22.65M21.67M21.72M21.4M
Income Before Nonrecurring Items-14.94M-13.05M-11.1M-9.1M-6.95M-5.35M
Income from Nonrecurring Items------
Neuroderm Earnings Per Share Basic Net
-0.57-0.50-0.49-0.42-0.32-0.25
Neuroderm Earnings Per Share Diluted Net
-0.57-0.50-0.49-0.42-0.32-0.25
EPS Diluted Before Nonrecurring Items-0.57-0.50-0.49-0.42-0.32-0.25
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Neuroderm stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Neuroderm revenue chart, implies that the company is growing. It has not been the case with Neuroderm. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-14.94M for NDRM stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The NDRM financials along with Neuroderm historical stock prices provide a lot of details about the firm.

Neuroderm Income Statement - Key Financial Ratios